Aemetis (AMTX) Reports Q4 Loss, Misses Revenue Estimates

Core Insights - Aemetis reported a quarterly loss of $0.24 per share, better than the Zacks Consensus Estimate of a loss of $0.27, and an improvement from a loss of $0.36 per share a year ago, resulting in an earnings surprise of +11.11% [1] - The company posted revenues of $43.31 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 37.6% and down from $47 million in the same quarter last year [2] - Aemetis shares have increased by approximately 10.8% since the beginning of the year, contrasting with a 1% decline in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.20 on revenues of $95.45 million, and for the current fiscal year, it is -$0.54 on revenues of $456.85 million [7] - The estimate revisions trend for Aemetis was mixed prior to the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Biofuels industry, to which Aemetis belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting that companies in the top half of the Zacks-ranked industries tend to outperform those in the bottom half by more than 2 to 1 [8]